精品课件进展期胃癌个体化药物治疗.pptxVIP

进展期胃癌个体化药物治疗——药物优化与个体化探索;目前胃癌化疗药物;Randomized Phase III Study In First Line For AGC ;胃癌化疗存在的临床问题;方案的改良;如何优化方案;;; Taxol: TP Induction and Enhancement of antitumor activity of Xeloda;如何优化方案;A phase II study of Capecitabine in combination with paclitaxel sequenced with capecitabine maintenance as 1st line therapy in advanced or recurrent gastric cancerML20312 (ongoing);Primary results---PTX+Cape sequenced with Cape;β-tubulin Ⅲ、TP、TS表达与XPa有效率的相关性;实验结果;Analysis the relationship of β－tubulin III expression and PFS 、 OS in AGC patients with CAPE+PTX;TS、DPYD、MTHFR基因分型与疗效、TTP及OS的相关性：;胃癌药